United Therapeutics Corpo... (UTHR)
312.02
5.14 (1.67%)
At close: Apr 02, 2025, 3:59 PM
312.00
-0.01%
After-hours: Apr 02, 2025, 05:43 PM EDT
United Therapeutics Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 |
| Net Income | 1.2B | 984.8M | 727.3M | 475.8M | 514.8M | -104.5M | 589.2M | 417.9M | 713.7M | 651.6M | 340.1M | 174.56M | 304.44M | 217.87M | 105.92M | 19.46M | -42.79M | 19.86M | 73.97M | 65.02M | 15.45M | -9.97M | -23.65M | -37.29M | -75.61M | -33.5M | -12.8M |
| Depreciation & Amortization | 72.5M | 53.2M | 51.3M | 49.9M | 49.9M | 45.9M | 35.9M | 31M | 31.6M | 32.9M | 32.2M | 31.26M | 27.14M | 20.54M | 17.92M | 11.39M | 4.54M | 957K | 1.46M | 2.41M | 2.28M | 2.33M | 3.13M | 3.51M | -79.74K | -1.3M | n/a |
| Stock-Based Compensation | 144M | 39.1M | 106.8M | 138.5M | 163.8M | 45.4M | -26.4M | 73.5M | 12.1M | 280.25M | 190.05M | 320.79M | 30.11M | -15.71M | 113.94M | 101.02M | 28.7M | -29.6M | -10.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | -55.6M | -82.8M | -150.6M | -112.9M | 16.8M | 16.3M | 4.7M | -61.4M | -71.8M | -181.82M | -322.08M | -201.75M | -145.76M | -95.7M | -39.43M | -18.73M | -2.89M | 1.65M | 7.71M | -1.7M | 1.8M | -1.85M | 355K | -1.63B | 3.86M | 1.8M | n/a |
| Other Non-Cash Items | -24.3M | -1.3M | 23.9M | 72.5M | 191M | -148M | 153.3M | 25.3M | -101.7M | -301.7M | -17M | 219.45M | -7.96M | 336.35M | 6.64M | 20.18M | -19.07M | 66.94M | 27.41M | -16.23M | 1.64M | 2.14M | 11.4M | 2.06M | 42.83M | 9.3M | 2M |
| Deferred Income Tax | n/a | n/a | -71.7M | -89.7M | -168.1M | -82.7M | -104.3M | n/a | n/a | n/a | 185.11M | 104.34M | 136.23M | -197.59M | 41.92M | -1.04M | -31.21M | -3.28M | -37.05M | -18.13M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -60.2M | -97.8M | -35.1M | -48.8M | 4.3M | 37.3M | 130.7M | -83.2M | -46.2M | -37.3M | -56.7M | -22.42M | -29.92M | -111.25M | -74.81M | -53.39M | 10.66M | -5.79M | -3.25M | -7.5M | 1.42M | -3.05M | -13.14M | -7.19M | 1.74M | 1.8M | 1.2M |
| Operating Cash Flow | 1.33B | 978M | 802.5M | 598.2M | 755.7M | -206.6M | 778.4M | 474.2M | 643.6M | 382.8M | 355.3M | 425.27M | 323.63M | 250.19M | 211.53M | 97.62M | -49.17M | 49.08M | 51.78M | 43.7M | 20.78M | -8.56M | -22.26M | -38.9M | -31.11M | -23.7M | -9.6M |
| Capital Expenditures | -246.5M | -230.4M | -138.8M | -120.8M | -59.3M | -83.7M | -184.4M | -86.3M | -43.2M | -49.79M | -47.44M | -31.91M | -111.91M | -35.98M | -18.64M | -95.4M | -124.42M | -38.66M | -15.63M | -6.12M | -5.22M | -7M | -3.58M | -687.29K | -639.88K | -2.3M | -1M |
| Acquisitions | n/a | -89.2M | 7.1M | 366.1M | 681.6M | -20.5M | -124.1M | 8.3M | -2.1M | n/a | n/a | -30.77M | n/a | -3.55M | n/a | 1.21M | -266.05M | -260.89M | -32.36M | n/a | 821K | n/a | 1K | n/a | -8.13M | n/a | n/a |
| Purchase of Investments | -1.65B | -2.51B | -1.71B | -1.9B | -2.31B | -1.28B | -867M | -830.6M | -38.9M | -117M | -163.67M | -762.2M | -579.32M | -815.68M | -662.23M | -310.63M | -345.96M | -301.99M | -207.15M | -78.06M | -37.47M | -44.71M | -11.22M | -152.52M | -56.66M | -114.3M | -10.5M |
| Sales Maturities Of Investments | 1.54B | 2.14B | 1.03B | 1.53B | 1.63B | 1.04B | 400.9M | 72.9M | 130.4M | 320.37M | 549.58M | 529.9M | 527.86M | 733.88M | 457.73M | 249.08M | 297.9M | 318.94M | 118.76M | 12.9M | 30M | n/a | 140.57M | 18.39M | 76.45M | 92.6M | n/a |
| Other Investing Acitivies | 772.8M | -23M | 3.5M | -366.1M | -679.2M | 8M | -636.2M | -749.3M | 86.3M | 553.4M | 385.9M | -263.06M | -51.46M | -1K | 13.9M | -4.78M | 266.05M | 260.89M | 32.36M | n/a | -1M | 4.18M | -5.41M | 40K | -3.87M | -100K | n/a |
| Investing Cash Flow | 417.2M | -719.6M | -811.5M | -486.9M | -738.5M | -335.4M | -820.6M | -835.6M | 48.3M | 503.6M | 338.5M | -294.97M | -163.36M | -121.33M | -209.24M | -160.52M | -172.48M | -21.71M | -104.03M | -71.28M | -12.87M | -47.54M | 120.36M | -134.78M | 7.16M | -24.1M | -11.5M |
| Debt Repayment | -400M | -100M | n/a | n/a | -50M | 600M | n/a | 250M | -8.8M | -133.2M | -177.8M | -1.32M | -999K | -8.57M | 38.56M | n/a | -23K | -10K | 242.01M | -795K | -774K | -2.08M | -60K | -80K | -58.52K | 1.1M | n/a |
| Common Stock Repurchased | -1.01B | -13.8M | -11.4M | -10.8M | -3.7M | -2.1M | n/a | -250M | -500M | -394.5M | -483.1M | -42.44M | -188M | -212M | n/a | n/a | n/a | -67.06M | -193.09M | n/a | n/a | n/a | n/a | -2.8M | -4.07M | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -29.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 157.4M | 101.9M | 86.8M | 55.6M | 36.8M | 13.3M | 6.3M | 43.3M | 11.1M | 80.7M | 84.3M | 38.64M | 19.86M | 2.49M | 108.2M | 36.48M | 63.03M | 87.95M | 10.76M | n/a | n/a | n/a | n/a | -299 | 159.42K | -200K | n/a |
| Financial Cash Flow | -1.25B | -11.9M | 75.4M | 44.8M | -16.9M | 611.2M | 6.3M | 43.3M | -497.7M | -447M | -576.6M | -5.12M | -169.14M | -218.08M | 146.76M | 36.48M | 213M | 20.88M | 74.13M | 14.17M | 6.32M | 2.01M | 185K | -2.88M | 206.61M | 59.3M | 22.9M |
| Net Cash Flow | 489.5M | 246.5M | 66.4M | 156.1M | 300K | 69.2M | -35.9M | -317.9M | 191.2M | 434.1M | 113.44M | 124.86M | -8.65M | -89.49M | 151.81M | -29.1M | -9.87M | 48.26M | 21.89M | -13.41M | 14.22M | -54.09M | 98.28M | -176.56M | 182.66M | 11.5M | 22.9M |
| Free Cash Flow | 1.08B | 747.6M | 663.7M | 477.4M | 696.4M | -290.3M | 594M | 387.9M | 600.4M | 333.01M | 307.86M | 393.36M | 211.72M | 214.22M | 192.89M | 2.22M | -173.59M | 10.43M | 36.15M | 37.58M | 15.56M | -15.57M | -25.84M | -39.59M | -31.75M | -26M | -10.6M |